Athens, 3 June 2026 

Euronext Athens announces the commencement of trading on Friday 5 June 2026 of 1,734,922 new ordinary shares of LAVIPHARM S.A. (ISIN: GRS246003008), following the share capital increase realized due to the exercise of rights to participate in the company’s stock option plan.